Comparative in vitro activity of five cathelicidin-derived sythetic peptides against Leptospira, Borrelia and Treponema pallidum

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue 6, 2002, Pages 895-902

  Sambri, Vittorio ^a   Marangoni, Antonella ^a   Giacani, Lorenzo ^a   Gennaro, Renato ^b   Murgia, Rossella ^c   Cevenini, Roberto ^a   Cinco, Marina ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Biofisica e Chimica delle Macromole   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Borrelia; Cathelicidin derived peptide; Leptospira; Treponema

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; PROTEIN BMAP 28; PROTEIN CRAMP; PROTEIN PG 1; PROTEIN SMAP 29; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII; CATTLE; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; HAMSTER; IN VITRO STUDY; INCUBATION TIME; INHIBITION KINETICS; LEPTOSPIRA INTERROGANS; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHASE CONTRAST MICROSCOPY; SHEEP; SPECIES DIFFERENCE; SPIROCHETE; TREPONEMA PALLIDUM;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; BORRELIA; CATTLE; CELL SURVIVAL; CRICETINAE; HUMANS; LEPTOSPIRA; MALE; MESOCRICETUS; MICE; MICROBIAL SENSITIVITY TESTS; PROTEINS; RABBITS; SHEEP; SWINE; TREPONEMA PALLIDUM;

EID: 0036929153     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf220     Document Type: Article

References (43)

1. Gennaro, R. & Zanetti, M. (2000). Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers 55, 31-49.
2. Turner, J., Cho, Y., Dinh, N., Waring, A. J. & Lehrer, R. I. (1998). Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrobial Agents and Chemotherapy 42, 2206-14.
3. Ritonja, A., Kopitar, M., Jerala, R. & Turk, V. (1989). Primary structure of a new cysteine proteinase inhibitor from pig leucocytes. FEBS Letters 255, 211-4.
4. Zanetti, M., Litteri, L., Gennaro, R., Horstmann, H. & Romeo, D. (1990). Bactenecins, defense polypeptides of bovine neutrophils, are generated from precursor molecules stored in the large granules. Journal of Cell Biology 111, 1363-71.
5. Scocchi, M., Skerlavaj, B., Romeo, D. & Gennaro, R. (1992). Proteolytic cleavage by neutrophil elastase converts inactive storage proforms to antibacterial bactenecins. European Journal of Biochemistry 209, 589-95.
6. Sorensen, O. E., Follin, P., Johnsen, A. H., Calafat, J., Tjabringa, G. S., Hiemstra, P. S. et al. (2001). Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97, 3951-9.
7. Agerberth, B., Gunne, H., Odeberg, J., Kogner, P., Boman, H. G. & Gudmundsson, G. H. (1995). FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proceedings of the National Academy of Sciences, USA 92, 195-9.
8. Frohm Nilsson, M., Sandstedt, B., Sorensen, O., Weber, G., Borregaard, N. & Ståhle-Bäckdahl, M. (1999). The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infection and Immunity 67, 2561-6.
9. Frohm, M., Agerberth, B., Ahangari, G., Ståhle-Bäckdahl, M., Lidén, S., Wigzell, H. et al. (1997). The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. Journal of Biological Chemistry 272, 15258-63.
10. Agerberth, B., Charo, J., Werr, J., Olsson, B., Idali, F., Lindbom, L. et al. (2000). The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96, 3086-93.
11. Travis, S. M., Anderson, N. N., Forsyth, W. B., Espiritu, C., Conway, B. D., Greenberg, E. B. et al. (2000). Bactericidal activity of mammalian cathelicidin-derived peptides. Infection and Immunity 68, 2748-55.
12. Zanetti, M., Gennaro, R. & Romeo, D. (1995). Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Letters 374, 1-5.
13. Brogden, K. A., Kalfa, V. C., Ackermann, M. R., Palmquist, D. E., McCray, P. B., Jr & Tack, B. F. (2001). The ovine cathelicidin SMAP-29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection. Antimicrobial Agents and Chemotherapy 45, 331-4.
14. Gennaro, R., Scocchi, M., Benincasa, M., Skerlavaj, B., Risso, A., Miani M. et al. (2001). Cathelicidin-derived antimicrobial peptides: in vitro and in vivo activity. In Peptides 2000 (Martinez, J. & Fehrentz, J. A., Eds), pp. 14-18. Editions EDK, Paris, France.
15. Larrick, J. W., Hirata, M., Zheng, H., Zhong, J., Bolin, D., Cavaillon, J. M. et al. (1994). A novel granulocyte-derived peptide with lipopolysaccharide neutralizing activity. Journal of Immunology 152, 231-40.
16. Saiman, L., Tabibi, S., Starner, T. D., San Gabriel, P., Winokur, P. L., Jia, H. P. et al. (2001). Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis. Antimicrobial Agents and Chemotherapy 45, 2838-44.
17. Lusitani, D., Malawista, S. E. & Montgomery, R. R. (2002). Borrelia burgdorferi are susceptible to killing by a variety of human polymorphonuclear leucocyte components. Journal of Infectious Diseases 185, 797-804.
18. Garcia, R., Gusmani, L., Murgia, R., Guarnaccia, C., Cinco, M. & Rottini, G. (1998). Elastase is the human neutrophil granule protein responsible for the in vitro of the Lyme Disease spirochete Borrelia burgdorferi. Infection and Immunity 66, 1408-12.
19. Elsbach, P., Weiss, J. & Levy, O. (1999). Oxygen-independent antimicrobial systems of phagocytes. In Inflammation: Basic Principles and Clinical Correlates, 3rd edn (Gallin, J. I., Snyderman, R., Fearon, D. T., Haynes, B. F. & Nathan, C., Eds), pp. 801-17. Lippincott, Williams and Wilkins, Philadelphia, PA, USA.
20. Ellinghausen, H. C. & McCullough, W. G. (1965). Nutrition of Leptospira pomona and growth of 13 other serotypes: fractionation of oleic albumin complex and a medium of bovine albumin and polysorbate 80. American Journal of Veterinary Research 26, 45-51.
21. Marangoni, A., Aldini, R., Sambri, V., Montagnani, M., Ballardini, G., Storni, E. et al. (2000). Uptake and killing of Leptospira interrogans and Borrelia burgdorferi, spirochetes pathogenic to humans, by reticuloendothelial cells in perfused rat liver. Infection and Immunity 68, 5408-11.
22. Sambri, V., Marangoni, A., Massaria, F., Farencena, A., La Placa, M., Jr & Cevenini, R. (1995). Functional activities of antibodies directed against surface lipoproteins of Borrelia hermsii. Microbiology and Immunology 39, 623-7.
23. Sambri, V., Marangoni, A., Olmo, A., Storni, E., Montagnani, M., Fabbi, M. et al. (1999). Specific antibodies reactive with the 22-Kilodalton major outer surface protein of Borrelia anserina Ni-NL protect chicks from infection. Infection and Immunity 67, 2633-7.
24. Marangoni, A., Sambri, V., Storni, E., D'Antuono, A., Negosanti, M. & Cevenini, R. (2000). Treponema pallidum surface immunofluorescence assay for serologic diagnosis of syphilis. Clinical and Diagnostic Laboratory Immunology 7, 417-21.
25. Bagella, L., Scocchi, M. & Zanetti, M. (1995). cDNA sequences of three sheep myeloid cathelicidins. FEBS Letters 376, 225-8.
26. Skerlavaj, B., Benincasa, M., Risso, A., Zanetti, M. & Gennaro, R. (1999). SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes. FEBS Letters 463, 58-62.
27. Gallo, R. L., Kim, K. J., Bernfield, M., Kozak, C. A., Zanetti, M., Merluzzi, L. et al. (1997). Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. Journal of Biological Chemistry 272, 13088-93.
28. Skerlavaj, B., Gennaro, R., Bagella, L., Merluzzi, L., Risso, A. & Zanetti, M. (1996). Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. Journal of Biological Chemistry 271, 28375-81.
29. Kokryakov, V. N., Harwig, S. S. L., Panyutich, E. A., Shevchenko, A. A., Aleshina, G. M., Shamova, O. V. et al. (1993). Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Letters 327, 231-6.
30. Levin, J. M., Nelson, J. A., Segreti, J., Harrison, B., Benson, C. A. & Strle, F. (1993). In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents. Antimicrobial Agents and Chemotherapy 37, 1444-6.
31. Agger, W. A., Callister, S. M. & Jobe, D. A. (1992). In vitro susceptibilities of Borrelia burgdorferi to five oral cephalosporins and ceftriaxone. Antimicrobial Agents and Chemotherapy 36, 1788-90.
32. Nelson, R. A. & Mayer, M. M. (1949). Immobilization of Treponema pallidum in vitro by antibody produced in syphilitic infection. Journal of Experimental Medicine 89, 369-93.
33. Dever, L. L., Jorgensen, J. H. & Barbour, A. G. (1992). In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies. Journal of Clinical Microbiology 30, 2692-7.
34. Norris, S. J. & Edmondson, D. J. (1988). In vitro culture system to determine MICs and MBCs of antimicrobial agents against Treponema pallidum subsp. pallidum (Nichols strain). Antimicrobial Agents and Chemotherapy 32, 68-74.
35. Norris, S. J. & Larsen, S. A. (1995). Treponema and host-associated spirochetes. In Manual of Clinical Microbiology, 6th edn (Murray, P. R., Baron, E. J., Pfaller, M. A., Tenover, F. C. & Volken, R. H., Eds), pp. 636-51. American Society for Microbiology, Washington, DC, USA.
36. Sambri, V., Marangoni, A., Eyer, C., Reichhuber, C., Soutschek, E., Negosanti, M. et al. (2001). Western immunoblotting with five Treponema pallidum recombinant antigens for serologic diagnosis of syphilis. Clinical and Diagnostic Laboratory Immunology 8, 534-9.
37. Byrne, R. E., Laska, S., Bell, M., Larson, D., Phillis, J. & Todd, J. (1992). Evaluation of a Treponema pallidum Western immunoblot assay as a confirmatory test for syphilis. Journal of Clinical Microbiology 33, 115-22.
38. Borenstein, L. A., Selsted, M. E., Lehrer, R. I. & Miller, J. N. (1991). Antimicrobial activity of rabbit leukocyte defensins against Treponema pallidum subsp. pallidum. Infection and Immunity 59, 1359-67.
39. Borenstein, L. A., Ganz, T., Sell, S., Lehrer, R. I. & Miller, J. N. (1991). Contribution of rabbit leukocyte defensins to the host response in experimental syphilis. Infection and Immunity 59, 1368-77.
40. Scocchi, M., Romeo, D. & Cinco, M. (1993). Antimicrobial activity of two bactenecins against spirochetes. Infection and Immunity 61, 3081-3.
41. Lehrer, R. I., Barton, A. & Ganz, T. (1988) Concurrent assessment of inner and outer membrane permeabilization and bacteriolysis in Escherichia coli by multiple-wavelength spectrophotometry. Journal of Immunological Methods 108, 153-8.
42. Hardy, P. H., Jr & Levin, J. (1983). Lack of endotoxin in Borrelia hispanica and Treponema pallidum. Proceedings of the Society for Experimental Biology and Medicine 174, 47-52.
43. Takayama, K., Rothenberg, R. J. & Barbour, A. G. (1987). Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infection and Immunity 55, 2311-3.